Trial · NCT01335477
Outcomes29
Each outcome the trial posted results for, in ClinicalTrials.gov's words.
1 to 20 of 29
Download this page as JSON| Type | Outcome | Time frame | Population | Units | Measured as |
|---|---|---|---|---|---|
| PRIMARY | Annual Rate of Decline in Forced Vital Capacity (FVC) Over 52 Weeks. | 52 weeks | Treated Set | mL/year | MEAN |
| SECONDARY | Change From Baseline in Saint George's Respiratory Questionnaire (SGRQ) Total Score at 52 Weeks | Baseline and 52 weeks | Treated Set (Only patients with observed cases (OC) values were analysed) | points on a scale | MEAN |
| SECONDARY | Time to First Acute Idiopathic Pulmonary Fibrosis (IPF) Exacerbation | 52 weeks | Treated Set | percentage of participants | NUMBER |
| SECONDARY | Absolute Change From Baseline in Forced Vital Capacity (FVC) Over 52 Weeks | Baseline and 52 weeks | Treated Set (Only patients with observed cases (OC) values were analysed) | mL | MEAN |
| SECONDARY | Relative Change From Baseline in Forced Vital Capacity (FVC) Over 52 Weeks | Baseline and 52 weeks | Treated Set (Only patients with observed cases (OC) values were analysed) | percent change | MEAN |
| SECONDARY | Absolute Change From Baseline in Forced Vital Capacity (FVC) (% Predicted) Over 52 Weeks | Baseline and 52 weeks | Treated Set (Only patients with observed cases (OC) values were analysed) | %predicted | MEAN |
| SECONDARY | Relative Change From Baseline in Forced Vital Capacity (FVC) (% Predicted) Over 52 Weeks | Baseline and 52 weeks | Treated Set (Only patients with observed cases (OC) values were analysed) | percent change | MEAN |
| SECONDARY | Absolute Categorical Change From Baseline of FVC (% Predicted) by Categories Over 52 Weeks - 5% Threshold | Baseline and 52 weeks | Treated Set (for patients with change from baseline in FVC (% predicted) at Week 52) | percentage of participants | NUMBER |
| SECONDARY | Absolute Categorical Change From Baseline of FVC (% Predicted) by Categories Over 52 Weeks - 10% Threshold | Baseline and 52 weeks | Treated Set (for patients with change from baseline in FVC (% predicted) at Week 52) | percentage of participants | NUMBER |
| SECONDARY | FVC Responders Using 10% Threshold at 52 Weeks | 52 weeks | Treated Set | percentage of participants | NUMBER |
| SECONDARY | Proportion of FVC Responders Using 5% Threshold at 52 Weeks | 52 weeks | Treated Set | percentage of participants | NUMBER |
| SECONDARY | Proportion of SGRQ Responders at 52 Weeks: Patient Reported Outcomes (PROs) | baseline and 52 weeks | Treated Set | percentage of participants | NUMBER |
| SECONDARY | Change From Baseline in SGRQ Symptom Score at 52 Weeks (Points): Patient Reported Outcomes (PROs) | baseline and 52 weeks | Treated Set (Only patients with observed cases (OC) values were analysed) | points on a scale | MEAN |
| SECONDARY | Change From Baseline in SGRQ Impact Score at 52 Weeks (Points): Patient Reported Outcomes (PROs) | baseline and 52 weeks | Treated Set (Only patients with observed cases (OC) values were analysed) | points on a scale | MEAN |
| SECONDARY | Change From Baseline in SGRQ Activity Score at 52 Weeks (Points): Patient Reported Outcomes (PROs) | baseline and 52 weeks | Treated Set (Only patients with observed cases (OC) values were analysed) | points on a scale | MEAN |
| SECONDARY | Change From Baseline in Idiopathic Pulmonary Fibrosis (IPF) Specific Version of SGRQ (SGRQ-I) Total Score at 52 Weeks (Points): Patient Reported Outcomes (PROs) | baseline and 52 weeks | Treated Set (Only patients with observed cases (OC) values were analysed) | points on a scale | MEAN |
| SECONDARY | Change From Baseline in Shortness of Breath Questionnaire (SOBQ) at 52 Weeks: Patient Reported Outcomes (PROs) | baseline and 52 weeks | Treated Set (Only patients with observed cases (OC) values were analysed) | points on a scale | MEAN |
| SECONDARY | Change From Baseline in Cough Symptom Score of the Cough and Sputum Assessment Questionnaire (CASA-Q) Score at 52 Weeks: Patient Reported Outcomes (PROs) | baseline and 52 weeks | Treated Set (Only patients with observed cases (OC) values were analysed) | points on a scale | MEAN |
| SECONDARY | Change From Baseline in Cough Impact Score of the Cough and Sputum Assessment Questionnaire (CASA-Q) Score at 52 Weeks: Patient Reported Outcomes (PROs) | baseline and 52 weeks | Treated Set (Only patients with observed cases (OC) values were analysed) | points on a scale | MEAN |
| SECONDARY | Proportion of Patient's Global Impression of Change (PGI-C) Responders at 52 Weeks: Patient Reported Outcomes (PROs) | 52 weeks | Treated Set | percentage of participants | NUMBER |
Source ClinicalTrials.govtrials-2026-11-12-0.5.0
Sources 3
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNo license stated
- NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
- NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/trials/v1/NCT01335477/outcomes